APA Zitierstil

Sougawa, N., Miyagawa, S., Fukushima, S., Kawamura, A., Yokoyama, J., Ito, E., . . . Sawa, Y. (2018). Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy. Sci Rep.

Chicago Zitierstil

Sougawa, Nagako, et al. "Immunologic Targeting of CD30 Eliminates Tumourigenic Human Pluripotent Stem Cells, Allowing Safer Clinical Application of HiPSC-based Cell Therapy." Sci Rep 2018.

MLA Zitierstil

Sougawa, Nagako, et al. "Immunologic Targeting of CD30 Eliminates Tumourigenic Human Pluripotent Stem Cells, Allowing Safer Clinical Application of HiPSC-based Cell Therapy." Sci Rep 2018.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.